Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (611-620 of 740) with videos related to

Pageof 74
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2023
An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent InfectionsKrishna Rao, Qianzi Zhao, Justin Bell, et al.
Lancet (London, England)|November 5, 1997
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating CommitteeF Brun-Vézinet, C Boucher, C Loveday, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today's CliniciansJuan P Horcajada, Ana Gales, Burcu Isler, et al.
Infection Control and Hospital Epidemiology|March 8, 2014
Statewide surveillance of carbapenem-resistant enterobacteriaceae in MichiganBrenda M Brennan, Joseph R Coyle, Dror Marchaim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2013
Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyC Fotopoulou, I Vergote, P Mainwaring, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 12, 2020
Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational studyMerlin Moni, A Sangita Sudhir, T S Dipu, et al.
Clinical Microbiology Reviews|October 9, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>Juan P Horcajada, Ana C Gales, Burcu Isler, et al.
Scandinavian Journal of Infectious Diseases|July 11, 2008
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infectionsTahaniyat Lalani, Vivian H Chu, Chelsea A Grussemeyer, et al.
AIDS Research and Human Retroviruses|September 10, 1999
The rabbit study: ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patientsD R Churchill, A S Pym, S Galpin, et al.
The Lancet. Infectious Diseases|December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trialMichael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Pageof 74

Showing results (611-620 of 740) with videos related to

Sort By:
Pageof 74
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2023
An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent InfectionsKrishna Rao, Qianzi Zhao, Justin Bell, et al.
Lancet (London, England)|November 5, 1997
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating CommitteeF Brun-Vézinet, C Boucher, C Loveday, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today's CliniciansJuan P Horcajada, Ana Gales, Burcu Isler, et al.
Infection Control and Hospital Epidemiology|March 8, 2014
Statewide surveillance of carbapenem-resistant enterobacteriaceae in MichiganBrenda M Brennan, Joseph R Coyle, Dror Marchaim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2013
Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyC Fotopoulou, I Vergote, P Mainwaring, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 12, 2020
Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational studyMerlin Moni, A Sangita Sudhir, T S Dipu, et al.
Clinical Microbiology Reviews|October 9, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>Juan P Horcajada, Ana C Gales, Burcu Isler, et al.
Scandinavian Journal of Infectious Diseases|July 11, 2008
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infectionsTahaniyat Lalani, Vivian H Chu, Chelsea A Grussemeyer, et al.
AIDS Research and Human Retroviruses|September 10, 1999
The rabbit study: ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patientsD R Churchill, A S Pym, S Galpin, et al.
The Lancet. Infectious Diseases|December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trialMichael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Pageof 74